Amelioration of Amyloid β-Induced Cognitive Deficits by Zataria multiflora Boiss. Essential Oil in a Rat Model of Alzheimer's Disease

CNS Neuroscience and Therapeutics

Volumn 18, Issue 4, 2012, Pages 295-301

  Majlessi, Nahid ^a   Choopani, Samira ^a   Kamalinejad, Mohammad ^b   Azizi, Zahra ^a  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acute toxicity; Iranian traditional medicine; Lamiaceae; Morris water maze

Indexed keywords

AMYLOID BETA PROTEIN[25-35]; ESSENTIAL OIL;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG MECHANISM; LATENT PERIOD; MALE; MAZE TEST; NONHUMAN; RAT; TOXICITY TESTING; ZATARIA MULTIFLORA;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; LAMIACEAE; MALE; MAZE LEARNING; MICE; OILS, VOLATILE; PEPTIDE FRAGMENTS; PLANT LEAVES; RATS; RATS, WISTAR;

EID: 84859500111     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/j.1755-5949.2011.00237.x     Document Type: Article

References (60)

1. Qiu C, Kivipelto M, von Strauss E. Epidemiology of Alzheimer's disease: Occurrence, determinants, and strategies toward intervention. Dialogues Clin Neurosci 2009;11:111-128.
2. Ziegler-Graham K, Brookmeyer R, Johnson E, Arrighi HM. Worldwide variation in the doubling time of Alzheimer's disease incidence rates. Alzheimers Dement 2008;4:316-323.
3. Christensen DD, Lin P. Practical treatment strategies for patients with Alzheimer's disease. J Fam Pract 2007;56:S17-S23.
4. Law A, Gauthier S, Quirion R. Say NO to Alzheimer's disease: The putative links between nitric oxide and dementia of the Alzheimer's type. Brain Res Brain Res Rev 2001;35:73-96.
5. Rodrigue KM, Kennedy KM, Park DC. Beta-amyloid deposition and the aging brain. Neuropsychol Rev 2009;19:436-450.
6. Bharadwaj PR, Dubey AK, Masters CL, Martins RN, Macreadie IG. Abeta aggregation and possible implications in Alzheimer's disease pathogenesis. J Cell Mol Med 2009;13:412-421.
7. Akiyama H, Barger S, Barnum S, et al. Inflammation and Alzheimer's disease. Neurobiol Aging 2000;21:383-421.
8. Moreira PI, Duarte AI, Santos MS, Rego AC, Oliveira CR. An integrative view of the role of oxidative stress, mitochondria and insulin in Alzheimer's disease. J Alzheimers Dis 2009;16:741-761.
9. Bassil N, Grossberg GT. Novel regimens and delivery systems in the pharmacological treatment of Alzheimer's disease. CNS Drugs 2009;23:293-307.
10. Neugroschl J, Sano M. An update on treatment and prevention strategies for Alzheimer's disease. Curr Neurol Neurosci Rep 2009;9:368-376.
11. Lleó A, Greenberg SM, Growdon JH. Current pharmacotherapy for Alzheimer's disease. Annu Rev Med 2006;57:513-533.
12. Mimica N, Presecki P. Side effects of approved antidementives. Psychiatr Danub 2009;21:108-113.
13. Panza F, Solfrizzi V, Frisardi V, Capurso C, D'Introno A, Colacicco AM, Vendemiale G, Capurso A, Imbimbo BP. Disease-modifying approach to the treatment of Alzheimer's disease: From alpha-secretase activators to gamma-secretase inhibitors and modulators. Drugs Aging 2009;26:537-555.
14. Spencer B, Rockenstein E, Crews L, Marr R, Masliah E. Novel strategies for Alzheimer's disease treatment. Expert Opin Biol Ther 2007;7:1853-1867.
15. Farlow MR, Miller ML, Pejovic V. Treatment options in Alzheimer's disease: Maximizing benefit, managing expectations. Dement Geriatr Cogn Disord 2008;25:408-422.
16. Steele M, Stuchbury G, Münch G. The molecular basis of the prevention of Alzheimer's disease through healthy nutrition. Exp Gerontol 2007;42:28-36.
17. Howes MJ, Perry NS, Houghton PJ. Plants with traditional uses and activities, relevant to the management of Alzheimer's disease and other cognitive disorders. Phytother Res 2003;17:1-18.
18. May BH, Lit M, Xue CC, et al. Herbal medicine for dementia: A systematic review. Phytother Res 2009;23:447-459.
19. Mukherjee PK, Kumar V, Mal M, Houghton PJ. Acetylcholinesterase inhibitors from plants. Phytomedicine 2007;14:289-300.
20. Anekonda TS, Reddy PH. Can herbs provide a new generation of drugs for treating Alzheimer's disease? Brain Res Brain Res Rev 2005;50:361-376.
21. Bastianetto S, Quirion R. Natural extracts as possible protective agents of brain aging. Neurobiol Aging 2002;23:891-897.
22. Kalaria RN, Maestre GE, Arizaga R, et al.; World Federation of Neurology Dementia Research Group. Alzheimer's disease and vascular dementia in developing countries: Prevalence, management, and risk factors. Lancet Neurol 2008;7:812-826.
23. Kim DS, Kim JY, Han YS. Alzheimer's disease drug discovery from herbs: Neuroprotectivity from beta-amyloid (1-42) insult. J Altern Complement Med 2007;13:333-340.
24. Kim J, Lee HJ, Lee KW. Naturally occurring phytochemicals for the prevention of Alzheimer's disease. J Neurochem 2010;112:1415-1430.
25. Ali MS, Saleem M, Ali Z, Ahmad VU. Chemistry of Zataria multiflora (Lamiaceae). Phytochemistry 2000;55:933-936.
26. Zargari A. Medicinal plants, 4th ed. Vol. 4. Tehran: Tehran University Press, 1990 (in Persian).
27. Mahboubi M, Bidgoli FG. Antistaphylococcal activity of Zataria multiflora essential oil and its synergy with vancomycin. Phytomedicine 2010;17:548-550.
28. Simbar M, Azarbad Z, Mojab F, Majd HA. A comparative study of the therapeutic effects of the Zataria multiflora vaginal cream and metronidazole vaginal gel on bacterial vaginosis. Phytomedicine 2008;15:1025-1031.
29. Amanlou M, Beitollahi JM, Abdollahzadeh S, Tohidast-Ekrad Z. Miconazole gel compared with Zataria multiflora Boiss. gel in the treatment of denture stomatitis. Phytother Res 2006;20:966-969.
30. Khosravi AR, Eslami AR, Shokri H, Kashanian M. Zataria multiflora cream for the treatment of acute vaginal candidiasis. Int J Gynaecol Obstet 2008;101:201-202.
31. Mahmoudabadi AZ, Dabbagh MA, Fouladi Z. In vitro anti-candida activity of Zataria multiflora Boiss. Evid Based Complement Alternat Med 2007;4:351-353.
32. Ziegler HL, Franzyk H, Sairafianpour M, et al. Erythrocyte membrane modifying agents and the inhibition of Plasmodium falciparum growth: Structure-activity relationships for betulinic acid analogues. Bioorg Med Chem 2004;12:119-127.
33. Hosseinzadeh H, Ramezani M, Salmani G. Antinociceptive, anti-inflammatory and acute toxicity effects of Zataria multiflora Boiss extracts in mice and rats. J Ethnopharmacol 2000;73:379-385.
34. Jaffary F, Ghannadi A, Siahpoush A. Antinociceptive effects of hydroalcoholic extract and essential oil of Zataria multiflora. Fitoterapia 2004;75:217-220.
35. Nakhai LA, Mohammadirad A, Yasa N, et al. Benefits of Zataria multiflora Boiss in experimental model of mouse inflammatory bowel disease. Evid Based Complement Alternat Med 2007;4:43-50.
36. Saei-Dehkordi SS, Tajik H, Moradi M, Khalighi-Sigaroodi F. Chemical composition of essential oils in Zataria multiflora Boiss. from different parts of Iran and their radical scavenging and antimicrobial activity. Food Chem Toxicol 2010;48:1562-1567.
37. Saleem M, Nazli R, Afza N, Sami A, Ali MS. Biological significance of essential oil of Zataria multiflora Boiss. Nat Prod Res 2004;18:493-497.
38. Shafiee A, Javidnia K. Composition of essential oil of Zataria multiflora. Planta Med 1997;63:371-372.
39. Jukic M, Politeo O, Maksimovic M, Milos M, Milos M. In vitro acetylcholinesterase inhibitory properties of thymol, carvacrol and their derivatives thymoquinone and thymohydroquinone. Phytother Res 2007;21:259-261.
40. Paxinos G, Watson C. The rat brain in stereotaxic coordinates, 2nd ed. Orlando, FL: Academic Press, 1986.
41. Majlessi N, Choopani S, Bozorgmehr T, Azizi Z. Involvement of hippocampal nitric oxide in spatial learning in the rat. Neurobiol Learn Mem 2008;90:413-419.
42. Lorke D. A new approach to practical acute toxicity testing. Arch Toxicol 1983;54:275-287.
43. Van Dam D, De Deyn PP. Drug discovery in dementia: The role of rodent models. Nat Rev Drug Discov 2006;5:956-970.
44. Stéphan A, Phillips AG. A case for a non-transgenic animal model of Alzheimer's disease. Genes Brain Behav 2005;4:157-172.
45. Thathiah A, De Strooper B. G protein-coupled receptors, cholinergic dysfunction, and Abeta toxicity in Alzheimer's disease. Sci Signal 2009;2:re8.
46. Yamin G. NMDA receptor-dependent signaling pathways that underlie amyloid beta-protein disruption of LTP in the hippocampus. J Neurosci Res 2009;87:1729-1736.
47. Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH. Mechanisms underlying inflammation in neurodegeneration. Cell 2010;140:918-934.
48. McNaull BB, Todd S, McGuinness B, Passmore AP. Inflammation and anti-inflammatory strategies for Alzheimer's disease-a mini-review. Gerontology 2010;56:3-14.
49. Shi Q, Gibson GE. Oxidative stress and transcriptional regulation in Alzheimer disease. Alzheimer Dis Assoc Disord 2007;21:276-291.
50. Bennett S, Grant MM, Aldred S. Oxidative stress in vascular dementia and Alzheimer's disease: A common pathology. J Alzheimers Dis 2009;17:245-257.
51. Kaminsky YG, Marlatt MW, Smith MA, Kosenko EA. Subcellular and metabolic examination of amyloid-beta peptides in Alzheimer disease pathogenesis: Evidence for Abeta (25-35). Exp Neurol 2010;221:26-37.
52. Manczak M, Mao P, Calkins MJ, et al. Mitochondria-targeted antioxidants protect against amyloid-beta toxicity in Alzheimer's disease neurons. J Alzheimers Dis 2010;20:S609-S631.
53. Ray B, Lahiri DK. Neuroinflammation in Alzheimer's disease: Different molecular targets and potential therapeutic agents including curcumin. Curr Opin Pharmacol 2009;9:434-444.
54. Patwardhan B, Mashelkar RA. Traditional medicine-inspired approaches to drug discovery: Can Ayurveda show the way forward? Drug Discov Today 2009;14:804-811.
55. Kim DS, Park SY, Kim JK. Curcuminoids from Curcuma longa L. (Zingiberaceae) that protect PC12 rat pheochromocytoma and normal human umbilical vein endothelial cells from betaA(1-42) insult. Neurosci Lett 2001;303:57-61.
56. Chang RC, So KF. Use of anti-aging herbal medicine, Lycium barbarum, against aging-associated diseases. What do we know so far? Cell Mol Neurobiol 2008;28:643-652.
57. Pendry B, Busia K, Bell CM. Phytochemical evaluation of selected antioxidant-containing medicinal plants for use in the preparation of a herbal formula-A preliminary study. Chem Biodivers 2005;2:917-922.
58. Savelev SU, Okello EJ, Perry EK. Butyryl- and acetyl-cholinesterase inhibitory activities in essential oils of Salvia species and their constituents. Phytother Res 2004;18:315-324.
59. Sucher NJ, Carles MC. Genome-based approaches to the authentication of medicinal plants. Planta Med 2008;74:603-623.
60. Gómez-Galera S, Pelacho AM, Gené A, Capell T, Christou P. The genetic manipulation of medicinal and aromatic plants. Plant Cell Rep 2007;26:1689-1715.